Fengchun Zhang

8PUBLICATIONS
39CO-AUTHORS
Litigation, adjudication and dispute resolutionGene expression (incl. microarray and other genome-wide approaches)Gastroenterology and hepatologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Social epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 18, 2026
Twelve-month follow-up after telitacicept withdrawal in patients with SLE: a single-centre study.

Zhaoyang Fan, Yi Wei, Chunting Guo

|Feb 26, 2025
Risk Allele rs117026326-Mediated Alternative Splicing of GTF2I Promotes B Cell Proliferation in Primary Sjögren's Syndrome.

Chaowen Luo, Chaofeng Lian, Jinlei Sun

|Jun 12, 2024
Glomerulonephritis in primary biliary cholangitis in China: an important complication.

Sainan Bian, Li Wang, Yunyun Fei

|Dec 21, 2023
Telitacicept in patients with active systemic lupus erythematosus: results of a phase 2b, randomised, double-blind, placebo-controlled trial.

Di Wu, Jing Li, Dong Xu

|Oct 08, 2022
Efficacy of belimumab in patients with systemic lupus erythematosus from North East Asia: Results of exploratory subgroup analyses.

Jie Zheng, Jieruo Gu, Yin Su

|Apr 16, 2022
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years.

Fengchun Zhang, Jie Zheng, Yang Li

Pageof 2

Frequent Collaborators

2 joint publications

David A Roth

2 joint publications

Damon L Bass

1 joint publications

Ying Pan

1 joint publications

Jing Wang